Results 171 to 180 of about 11,313 (223)

MR Imaging of the Breast Using Gadolinium-DTPA

Journal of Computer Assisted Tomography, 1986
In a preliminary study 20 patients underwent breast examinations by magnetic resonance (MR) imaging without and with Gd-DTPA as contrast medium. All carcinomas enhanced, whereas dysplastic tissue enhanced slightly or not at all. Significant additional diagnostic information was available on the Gd-DTPA examinations in at least four of 20 cases compared
S H, Heywang, D, Hahn, H, Schmidt, I, Krischke, W, Eiermann, R, Bassermann, J, Lissner   +6 more
openaire   +2 more sources

Gadolinium — DTPA in magnetic resonance imaging of the brain

Neurosurgical Review, 1987
This report concerns a clinical trial with Gd-DTPA as an intravenous contrast medium for MRI in patients with neurological disorders. 50 patients (30 female, 20 male) were examined without and with Gd-DTPA and the results of CT scanning and MR scanning without and with Gd-DTPA were compared. All patients tolerated the contrast medium very well.
J, Valk, R G, De Slegte, F C, Crezee, G J, Hazenberg, S I, Thjaha   +4 more
openaire   +2 more sources

Gadolinium-DTPA Enhancement of Lung Radiation Fibrosis

Journal of Computer Assisted Tomography, 1989
Gadolinium-diethylenetriamine pentaacetic acid (DTPA) enhancement of radiation-induced apical pulmonary fibrosis was observed in two patients previously treated for breast cancer. In one case the fibrosis was biopsied twice, with no change in its CT appearance over 3 years.
W C, Werthmuller, M L, Schiebler, R A, Whaley, M A, Mauro, W H, McCartney   +4 more
openaire   +2 more sources

Gadolinium-DTPA-enhanced MRI in the evaluation of osteonecrosis

Clinical Radiology, 1994
We report the MR findings in three cases of osteonecrosis. Two cases were post-traumatic and the third idiopathic. The diagnosis, localization and characterization of osteonecrosis was improved in all patients by the use of Gadolinium-DTPA-enhanced, fat-saturated, T1-weighted spin-echo imaging.
R, Uberoi, G, Tai, P M, Hughes
openaire   +2 more sources

Childhood chondrosarcoma: MR imaging with Gadolinium-DTPA

Magnetic Resonance Imaging, 1990
The radiologic, CT, MR, and histological features of a case of chondrosarcoma of the femur presenting in childhood are reported. This case emphasizes the use of correlative imaging in establishing the diagnosis as well as the value of MR supplemented by Gadolinium-DTPA enhancement in disclosing abundant necrosis within the tumor.
S L, Hanna, H L, Magill, D M, Parham, L C, Bowman, B D, Fletcher   +4 more
openaire   +2 more sources

Radiation myelopathy: significance of gadolinium-DTPA enhancement in the diagnosis

Neuroradiology, 1991
We described two cases of chronic progressive radiation myelopathy (CPRM), in which magnetic resonance imaging (MRI) was of great value for the diagnosis. Gadolinium-DTPA (Gd-DTPA) enhancement delineated precise lesions responsible for Brown-Séquard syndrome caused by CPRM in both cases.
M Sano, Sano M, Furukawa T
exaly   +3 more sources

Gadolinium-DTPA in Spinal Disease

Radiologic Clinics of North America, 1988
The use of paramagnetic contrast agents, in particular, gadolinium-DTPA, holds great promise for the MR evaluation of the spine. However, because of the lack of a previous model for intravenous contrast enhancement in the spine and because of some peculiarities of enhancement of spinal lesions, close attention must be paid to the appropriate uses of ...
openaire   +2 more sources

Safety of gadolinium‐DTPA: Extended clinical experience

Magnetic Resonance in Medicine, 1991
AbstractThis review reports data on the general and renal tolerance of the paramagnetic contrast agent Gd‐DTPA after intravenous administration. Gd‐DTPA was administered usually at a dose level of 0.1‐0.2 mmol/kg body wt (range: 0.005‐0.25 mmol/kg body wt) in cranial, spinal and body MR indications.
H P, Niendorf, J, Haustein, I, Cornelius, A, Alhassan, W, Clauss   +4 more
openaire   +2 more sources

Magnetic resonance imaging of the pancreas with gadolinium-DTPA

Gastrointestinal Radiology, 1991
Gadolinium (Gd)-DTPA was evaluated as a contrast agent for magnetic resonance (MR) imaging of the pancreas at 1.5T. Twenty-five patients were imaged with identical gradient-echo (GE) (TR 47, TE 13, 80 degree pulse angle) and spin-echo (SE) (TR 300, TE 15) MR sequences prior to and following an intravenous bolus of 0.1 mmol/kg Gd-DTPA. Marked pancreatic
J L, Chezmar, R C, Nelson, W C, Small, M E, Bernardino   +3 more
openaire   +2 more sources

In Vitro Interactions of Gadolinium DOTA Meglumine and Gadolinium DTPA Meglumine on Hemostasis

Investigative Radiology, 1988
The interactions of two gadolinium complexes (Gd-DOTA meglumine and Gd-DTPA meglumine) with hemostatic function have been analyzed using: (1) coagulation reactions (extrinsic and intrinsic pathways and fibrinoformation) and (2) platelet function investigations (aggregation, release of Ca++ and ATP after stimulation with collagen 2.5 micrograms/mL). The
C, Corot, J, Belleville, J, Paul, J, Baguet, M, Amiel, R, Eloy   +5 more
openaire   +2 more sources